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Abstract
The reported efficacy of BCG vaccine in
preventing pulmonary tuberculosis varies
from 0-80%; however, its efficacy in pre-
venting tuberculous meningitis ranges
from 520/%-84%. A case-control study was
conducted to assess the efficacy ofBCG in
preventing tuberculous meningitis in
children. New cases oftuberculous menin-
gitis, confirmed bacteriologically, were
registered as cases. Controls were children
suffering from febrile convulsions attend-
ing the same hospital. A total of 107 cases
and 321 controls, block matched for age,
were registered. Vaccination status was
determined from the history reported by
the mother and by BCG scar reading.
Data regarding socioeconomic status,
crowding, and nutritional status were col-
lected. Using multiple logistic regression
analysis the odds ratio obtained for the
presence ofBCG scar was 0-23 (95% confi-
dence interval (CI) 0-14 to 0.37) and the
protective efficacy ofBCG vaccine in pre-
venting tuberculous meningitis in children
was found to be 77% (95% CI 71 to 83%).
(Arch Dis Child 1996; 74: 144-147)
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Tuberculosis continues to be a widespread
disease especially in developing countries.
Tuberculous meningitis, a serious complication
of this infection, occurs in 7-12% of patients
with tuberculosis and it is more common in
children. 1 In children, even with treatment, the
mortality of tuberculous meningitis is 27% and
permanent disability is estimated to be as high
as 39%.2 BCG vaccination to control tubercu-
losis is still widely being used around the world,
but conflicting results from several large trials
have cast doubt about its efficacy in preventing
pulmonary tuberculosis.3- The Tuberculosis
Prevention Trial, conducted at Chenglepet
District, Madras did not show any protective
efficacy in preventing pulmonary tuberculosis.3
However, no special effort was made in this
trial to ascertain the efficacy ofBCG vaccine in
the prevention of extrapulmonary tuberculosis
in general or tuberculous meningitis in particu-
lar. The results from other studies undertaken
to find out the efficacy of BCG in preventing
tuberculous meningitis have been encouraging
and the protective efficacy has ranged from
52-84%.7-1o It is possible that BCG can pre-
vent tuberculous meningitis by preventing dis-
semination of the tubercle bacillus within the
body even if entry is not prevented."
A prospective study with sufficient power to
establish efficacy is not easy to conduct. Hence
a case-control study was designed to find out
the efficacy of BCG vaccine in preventing
tuberculous meningitis. This study also
assessed the role of poor nutrition and low




This study was conducted at the Institute of
Child Health and Hospital for Children,
Madras, from August 1990-December 1992.
Children aged 12 years or less were included in
the study.
Cases were selected from the inpatient
department of the hospital. Inclusion criteria
consisted of (a) two or more of the following
clinical features, with or without fever: altered
sensorium varying from drowsiness to coma,
headache, vomiting, history of convulsions,
meningeal signs, bulging fontanelle, papil-
loedema, cranial nerve palsy, and motor weak-
ness of the limbs, and (b) bacteriological
confirmation in the cerebrospinal fluid of
acid fast bacilli. Children with the following
conditions were excluded: tuberculous menin-
gitis treated before referral, chronic medical
illness or malignancy, and current immuno-
suppressive treatment.
During the study period, 406 cases clinically
suspected to be tuberculous meningitis were
admitted to the hospital. These cases were
examined in detail after getting informed
parental consent. Particulars regarding demo-
graphic data and BCG vaccination during the
neonatal period were elicited from the mothers
by a single medical officer throughout the
study period.
Bacteriological examination of the cerebro-
spinal fluid was carried out at the Tuberculosis
Research Centre, Madras for all these cases.
Acid fact bacilli were demonstrated, by culture
and/or smear, in the cerebrospinal fluid of 107
subjects who were registered as cases. These
children were also screened with chest radio-
graphy for evidence ofpulmonary tuberculosis.
SELECTION OF CONTROLS
Children attending the seizure clinic at the
same hospital during the same period and who
had febrile convulsions without other neuro-
logical abnormality were eligible control
subjects. After applying suitable exclusion cri-
teria as for cases, 321 controls were selected.
Cases and controls were block matched for age
and sex. Age matching was done within a range
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of + 2 months for children less than 2 years and
6 months in older children.
Cerebrospinal fluid analysis was not done
routinely for all controls. The ratio between
cases and controls was 1:3. The power of the
study was 80% to detect an odds ratio (OR) of
0 5. A total of 321 controls were registered.
MEASUREMENT
A precoded questionnaire was used to collect
data from cases and controls. The main out-
come measure, exposure to BCG vaccination,
was assessed from (a) BCG scar, (b) history of
vaccination as reported by the mother, and (c)
medical records if available. The presence of a
BCG scar was determined independently by a
medical officer and also by a trained para-
medical worker, at the time of first contact
with the patient. Exposure to BCG vaccina-
tion was classified as definite and probable.
Definite exposure indicated that both a BCG
scar and positive maternal history of BCG
vaccination were present. Probable exposure
indicated that either a BCG scar or maternal
history of BCG vaccination was present.
The scar reading made by the paramedical
worker was used to classify the vaccination
status.
Nutritional status of the children was classi-
fied as recommended by a subcommittee of the
Indian Academy of Pediatrics.12 According to
this, children were normal when weight was
>80% of expected weight for their height,
mildly malnourished when weight was 70-80%
of expected weight for their height, moderately
malnourished when weight was 60-70% of
expected weight for their height, and severely
malnourished when weight was <60% of
expected weight for their height.
Crowding was assessed by showing the
parent ofthe subjects rooms ofknown area and
then asking them to specify which room was
nearest in size to their own house. The total
number ofpeople living in the house was noted
and living space, as square foot per head, was
calculated.
Type of house was defined as kutcha or
pucca. A pucca house was one that had brick
walls, cement flooring, and roofing other than
thatched. When any one of the above was
absent the house was said to be kutcha. This
proxy measure was used to assess socioeco-
nomic status.
The mothers were asked about their educa-
tional status and were classified as follows:
never attended school, attended elementary
school, attended high school or college.
STATISTICAL METHODS
Univariate analysis and multiple logistic
regression analysis were carried out. Presence
of a BCG scar was taken as an independent
variable and disease status (tuberculous
meningitis) as the dependent variable in this
model. Covariates of interest in the regression
analysis included mothers' education, type of
house, nutritional status, and living space per
head. BMDP statistical software was used.
Results
The age of the 107 patients ranged from 6
months to 12 years. The number of children
under 5 years was 74 (69%), and boys consti-
tuted 63 (59%) of the total. The mothers of 75
(70%) of our cases never attended school. A
large proportion of patients (78, 73%) were
living in kutcha houses. The vast majority
(94%) of cases and controls were living in
houses with an area of less than 100 square
feet. Cases and controls were comparable with
respect to different characteristics (table 1).
Among cases, the chest radiograph was
normal in 71 (66%), pneumonitis was present
in 18 (17%), bronchopneumonia was present
in five (5%), and miliary tuberculosis in five
(5%). Hilar adenitis or thickened pleura were
seen in eight (7%) cases. Mantoux skin test
was positive (> 10 mm) in 13% of cases. Acid
fast bacilli were demonstrated in cerebrospinal
fluid by culture alone in 93 (87%) cases, by
smear alone in eight (7%) cases, and by both
smear and culture in six (6%) cases.
The chance corrected agreement (K) for scar
reading between the medical officer and the
paramedical worker was 0.8. A BCG scar was
present in 35 (33%) out of 107 cases and 219
(68%) out of 321 controls. From the mother's
history, exposure to BCG vaccination was
positive in 53 (50%) cases out of 107, and 259
(81%) controls out of 321. In 81 cases and 265
controls scar status and maternal history for
BCG vaccination were in total agreement.
Among this group, 31 (38%) out of 81 cases
and 211 (80%) out of 265 controls had both a
BCG scar and a positive maternal history for
BCG vaccination.
The effect of BCG vaccine upon risk of
development of tuberculous meningitis was
estimated separately by univariate analysis and
through multiple logistic regression analysis.
When the BCG scar was taken as the measure
of vaccination status, the OR was 0-23 (95%
confidence interval (CI) 0.14 to 0 37) and the






<2 36 (33) 106 (33)
2-<5 38 (36) 123 (38)
5-<8 21 (20) 60 (19)
8-12 12 (11) 32 (10)
Sex
Male 63 (59) 193 (60)
Female 44 (41) 128 (40)
Socioeconomic status
(1) Mother's education
Never attended school 75 (70) 88 (28)
Attended primary school 18 (17) 69 (22)
Attended high school/college 14 (13) 164 (50)
(2) Type of house
Kutcha 78 (73) 143 (45)
Pucca 29 (27) 178 (55)
(3) Crowding: living area (sq ft)
<50 71 (66) 187 (58)
50-100 30 (28) 114 (36)
>100 6 (6) 20 (6)
(4) Nutritional status*
<60 12 (11) 5 (2)
61-70 22 (21) 11 (3)
71-80 44 (41) 64 (20)
>80 29 (27) 241 (75)
*Actual weight expressed as a percentage of expected weight
for their height.
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Table 2 Efficacy ofBCG in preventing tuberculous
meningitis in various age groups
Age (years) OR (95% CI) Efficacy (95% CI)
<2 0-18 (0-08 to 0-44) 82% (75 to 90)
2-<5 0-21 (0 09 to 0 48) 79% (70 to 87)
5-<8 0-17 (0-05 to 0 58) 83% (74 to 94)
8-12 0-81 (0-17 to 3 73) 19% (O to >100)
vaccine efficacy was 77% (95% CI 71 to 83%).
When exposure to BCG vaccination was
assessed by maternal history alone, the OR was
023 (95% CI 0-14 to 0O39) and the vaccine
efficacy was 77% (95% CI 71 to 84%). When
both the BCG scar and a positive maternal
history of BCG vaccination were taken
together as evidence of exposure, the OR was
0O16 (95% CI 0O10 to 0.27) and the vaccine
efficacy was 84% (95% CI 80 to 88%). The
OR for BCG vaccination was calculated for
various age groups (table 2).
Among cases, 34 (32%) were moderately to
severely malnourished, whereas among controls
only 16 (5%) were moderately to severely mal-
nourished. The OR according to nutritional
status was calculated. The OR for severe and
moderate malnutrition was 0-37 (95% CI 0-09
to 1.48), for mild malnutrition 0-17 (95% CI
0 07 to 0 43), and for normal nutritional status
0-22 (95% CI 0O09 to 0 54). The protective
efficacy of BCG was 63% (95% CI 31 to 127)
in moderately to severely malnourished
patients, 83% (95% CI 76 to 91) in mildly
malnourished, and 78% (95% CI 68 to 89) in
patients with normal nutritional status.
Using logistic regression analysis, the OR
obtained for presence of BCG scar was 0-28
(95% CI 0-16 to 0 47), for better nutritional
status 0-16 (95% CI 0 05 to 0 59), for literate
mothers 0-36 (95% CI 0-26 to 0-51), for better
house type 0-52 (95% CI 0-29 to 0 93), and for
more living space per head 1-64 (95% CI 1-02
to 2.64).
The OR for the BCG scar estimated from
multiple regression analysis was almost the
same as the OR estimated from univariate
analysis. Various regression models were tried
and the OR for presence ofBCG scar was not
affected much by the presence of other vari-
ables in the model, for example nutritional
status, type of house, and mother's education.
Discussion
The efficacy of BCG vaccine in preventing
tuberculous meningitis was 77% in this study.
This observation is consistent with that of
others.8-10 Myint et al, however, reported that
BCG vaccine efficacy in preventing tubercu-
lous meningitis in children was 52%.7 In the
present study among children below 8 years
the efficacy ranged from 79%/o to 82%, but in
children above 8 years the efficacy was only
19%. This could have been due partially to
misclassification of the BCG status as well as
waning ofBCG efficacy with time.'3 However,
the number of children in this group was too
small to draw any definite conclusion. The
protective efficacy ofBCG was found to be low
in the moderately and severely malnourished
group. The influence of nutrition on the
efficacy of BCG vaccine is poorly understood
and needs to be evaluated further. Literacy of
mothers appeared to be an important risk
factor and this has to be assessed further in
future studies. The OR for better house type
was 0-52 but the OR for more living space per
head was 1 64. These contradicting values
could have been due to misclassification error
as a result of the wrong estimation of living
space. In the present study, type of house is a
reliable parameter compared with living space
per head as the latter involved the parent's
judgment about space. The OR for BCG
vaccination was not much different in the
presence of other parameters for different
regression models.
In case-control studies, case definition is
very crucial. Earlier studies defined cases either
clinically or used a combination of clinical and
bacteriological criteria other than cerebro-
spinal fluid culture. However, this study used a
more specific case diagnosis, demonstration of
acid fast bacilli in cerebrospinal fluid, as the
case definition of tuberculous meningitis, thus
decreasing misclassification bias.
Another potential source of bias is the ascer-
tainment of vaccination status. History of
vaccination, without evidence of a scar, must
be interpreted cautiously. Additionally, a BCG
scar may disappear over time. In order to
minimise this error, vaccination status was
classified into two categories: definite exposure
and probable exposure. The protective efficacy
was almost similar in these two groups, 84%
and 77% respectively, indicating that such a
misclassification was less likely to have
occurred in this study. Two more precautions
were taken to minimise measurement error
while identifying BCG scar. The paramedical
worker who examined the children for BCG
scar was unaware of the null hypothesis and
the scar reading was carried out before cer-
ebrospinal fluid culture results were available.
Ideal control subjects would have been neigh-
bourhood controls. But, with the available lim-
ited resources, identifying and recruiting
matched neighbourhood controls for cases com-
ing from different parts of the state was a limit-
ing factor. Hospital controls were more likely to
have received BCG vaccine than neighbour-
hood controls. However, in this study the pro-
portion of children who contacted the doctor at
least once for other vaccinations like diphtheria,
tetanus, and pertussis and oral polio virus were
equal in cases and controls. Thus it appears that
cases were comparable with controls with
respect to opportunities for being vaccinated
with BCG. Cases and controls were also similar
with reference to age, sex, and crowding.
This study shows BCG vaccine to be 77%
efficacious in preventing tuberculous meningi-
tis in children. Regardless of the protective
efficacy of BCG in preventing pulmonary
tuberculosis, in areas in which tuberculosis
affects a significant percentage of the popula-
tion, continued use ofBCG may be warranted
to prevent tuberculous meningitis.
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